Baillie Gifford & Co’s Foundation Medicine, Inc. FMI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-404,260
| Closed | -$55.3M | – | 231 |
|
|
2018
Q2 | $55.3M | Buy |
404,260
+13,843
| +4% | +$1.26M | 0.06% | 109 |
|
|
2018
Q1 | $30.7M | Buy |
390,417
+83,259
| +27% | +$6.14M | 0.04% | 123 |
|
|
2017
Q4 | $20.9M | Buy |
307,158
+51,368
| +20% | +$2.66M | 0.03% | 130 |
|
|
2017
Q3 | $10.3M | Buy |
255,790
+7,490
| +3% | +$289K | 0.01% | 160 |
|
|
2017
Q2 | $9.87M | Buy |
248,300
+73,500
| +42% | +$2.69M | 0.01% | 163 |
|
|
2017
Q1 | $5.64M | Hold |
174,800
| – | – | 0.01% | 168 |
|
|
2016
Q4 | $3.09M | Hold |
174,800
| – | – | 0.01% | 187 |
|
|
2016
Q3 | $4.08M | Hold |
174,800
| – | – | 0.01% | 181 |
|
|
2016
Q2 | $3.26M | Hold |
174,800
| – | – | 0.01% | 182 |
|
|
2016
Q1 | $3.18M | Hold |
174,800
| – | – | 0.01% | 182 |
|
|
2015
Q4 | $3.68M | Hold |
174,800
| – | – | 0.01% | 165 |
|
|
2015
Q3 | $3.23M | Buy |
174,800
+9,800
| +6% | +$245K | 0.01% | 175 |
|
|
2015
Q2 | $5.58M | Hold |
165,000
| – | – | 0.01% | 163 |
|
|
2015
Q1 | $7.94M | Hold |
165,000
| – | – | 0.02% | 158 |
|
|
2014
Q4 | $3.67M | Hold |
165,000
| – | – | 0.01% | 175 |
|
|
2014
Q3 | $3.13M | Buy |
+165,000
| New | +$3.93M | 0.01% | 184 |
|
Baillie Gifford & Co's FMI Position: Q3 2018 in Review
Baillie Gifford & Co sold out of Foundation Medicine, Inc. (FMI) in Q3 2018, closing a stake of 404,260 shares — an estimated $55.3M sold.
Baillie Gifford & Co first reported a position in FMI in Q3 2014 and held it in 16 quarters. The position peaked at $55.3M in Q2 2018. 0 funds tracked by Wall St. Rank hold FMI as of Q3 2018.
- Baillie Gifford & Co reported no remaining Foundation Medicine, Inc. position as of Q3 2018 after selling out during the quarter.
- Baillie Gifford & Co sold 404,260 Foundation Medicine, Inc. shares in Q3 2018, an estimated $55.3M.
- Baillie Gifford & Co first reported a position in Foundation Medicine, Inc. in Q3 2014 and held it in 16 quarters.
- Baillie Gifford & Co's Foundation Medicine, Inc. position peaked at $55.3M in Q2 2018.
- 0 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q3 2018.
Based on Baillie Gifford & Co's 13F filing for Q3 2018, filed 13 Nov 2018.